Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,751.5
44.3 (1.64%)

 

  • STI Straits Times Index
    2,751.5
    44.3 (1.64%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,556.3
    -5.5 (-0.35%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,770.4
    404.1 (1.66%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,930.8
    11.5 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,863.7
    168.0 (0.74%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,947.8
    31.1 (0.63%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,257.5M
  • Value: 1,627.4M
  • Rise: 285
  • Fall: 84
  • Unch: 440

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.191+0.004
Singtel2.630+0.050
ComfortDelGro1.620+0.050
MDR0.001-
SIA4.330-0.050
Synagie0.129+0.001
Genting Sing0.830+0.010
Parkson Retail^0.018+0.006
ThaiBev0.725+0.020
SPH1.360-0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,615.8 -67.1
HSI 24,770.4 +404.1
HSCEI 10,066.2 +98.3
Jakarta 4,947.8 +31.1
Nikkei 225 22,863.7 +168.0
SSE Comp 2,930.8 +11.6
Shanghai A 3,072.0 +12.1
Shanghai B 208.1 +2.5
KOSPI 2,181.9 +30.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BSTEAD BOUSTEAD HOLDINGS BHD
Quotes 15 Minutes Delayed. Updated at 05 Jun 2020 16:57
Last (MYR): 0.655 Change: -0.025 High: 0.675 Remarks:
Change (%): -3.68 Low: 0.645
Open 0.675 Yesterday's Close 0.680
Buy Price 0.650 Sell Price 0.655
Buy Volume ('00) 1,264 Sell Volume ('00) 1,150
Cumulative Volume ('00) 57,513 Cumulative Value 3,783,760
Click to show Stock Prices chart

Latest News

View All News

Key Statistics

EPS (MYR) a -0.63089 Trailing EPS (MYR) e -0.63089 NAV (MYR) b 1.8456
PE a - Trailing PE f - Price / NAV b 0.3549
Dividend (MYR) d - Cash In Hand (MYR) g 0.4639 Issued & Paid-up Shares c 2,026,988,000
Dividend Yield (%) d - Price / Cash In Hand g 1.412 Treasury Shares h -
Beta - 75 Daysi 1.512 R-Squared - 75 Days(%)i 28.27 Market Cap (M) 1,327.677
Beta - 500 Daysi 1.212 R-Squared - 500 Days (%)i 18.07 Enterprise Value (M) 10,298.177
Piotroski F Score 3 Exchange Code 2771 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 58.42 6-Month VWAP 0.562 Free Float (%) 87.1
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Pharmaceuticals: Major
Index Components BM INDUSTRIAL PRODUCTS & SERVICES / BM TRADING & SERVICES
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Apr 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BSTEAD Bursa 1,327.677 - - 0.3549 -
Industry DIVERSIFIED INDUSTRIALS Bursa 2,135.933 50.424 58.111 1.1211 3.696
Pharmaceuticals: Major Bursa 739.990 10.752 10.781 0.6708 0.206
Index BM INDUSTRIAL PRODUCTS & SERVICES Bursa 652.721 31.383 40.490 1.1644 2.417
BM TRADING & SERVICES Bursa 2,869.820 31.169 46.740 1.3370 2.896
Local Peer IGBB Bursa 2,344.700 11.237 11.237 0.7535 -
Local Peer PHARMA Bursa 660.912 - - 1.8885 -
Local Peer KOTRA Bursa 447.459 20.160 15.880 2.4612 2.381
Local Peer NOVA Bursa 227.187 20.761 16.503 2.7832 -
Local Peer BIOHLDG Bursa 127.052 15.271 15.279 0.7675 -
Local Peer SUNZEN Bursa 44.945 - - 0.4988 -
Global Peer JOHNSON & JOHNSON NYSE 386,573.391 25.569 22.520 6.3069 2.554
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 209,996.147 29.794 21.041 - 2.165
Global Peer MERCK & CO INC NYSE 205,840.355 20.912 20.286 7.8550 2.788
Global Peer PFIZER INC NYSE 200,029.428 12.293 12.668 3.0770 4.039
Global Peer ABBVIE INC NYSE 163,968.114 20.909 19.541 -22.1129 3.960
Global Peer ELI LILLY AND COMPANY NYSE 144,235.197 31.099 26.067 46.8480 1.713
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 141,382.892 105.468 190.098 - 2.543
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 137,775.194 40.063 144.418 2.7604 2.717
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 125,259.115 38.498 38.498 1.8935 2.349
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 116,620.110 19.972 19.409 14.5797 1.767
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), WUXI APPTEC (HKEx), INNOVENT BIO-B (HKEx), SINOPHARM (HKEx), REPLIGEN CORP (NASDAQ), CANSINOBIO-B (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), SH PHARMA (HKEx), JUNSHI BIO-B (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), BAIYUNSHAN PH (HKEx), NEKTAR THERAPEUTICS (NASDAQ), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINARES PHARMA (HKEx), ALLAKOS INC (NASDAQ), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), CMS (HKEx), AKESO-B (HKEx), HENLIUS-B (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), INNOCARE-B (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), CHINAGRANDPHARM (HKEx), TRAD CHI MED (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), SSY GROUP (HKEx), IGM BIOSCIENCES INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZYMEWORKS INC (NYSE), SPRINGWORKS THERAPEUTICS INC (NASDAQ), UNITED LAB (HKEx), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), TRICIDA INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), TONGRENTANGCM (HKEx), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), ORIC PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ATHENEX INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMARA INC (NASDAQ), PETIQ INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), HUA MEDICINE-B (HKEx), CRINETICS PHARMACEUTICALS INC (NASDAQ), SHINEWAY PHARM (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), BEYONDSPRING INC (NASDAQ), AC IMMUNE SA (NASDAQ), Kimia Farma Tbk. (IDX), FULCRUM THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), DURECT CORP (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FUSEN PHARM (HKEx), UROVANT SCIENCES LTD (NASDAQ), 89BIO INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), TOT BIOPHARM-B (HKEx), AFT PHARMACEUTICALS LTD (ASX), MENLO THERAPEUTICS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), LANNETT CO INC (NYSE), OVID THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), LIQUIDIA TECHNOLOGIES INC (NASDAQ), OBSEVA SA (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), DAWNRAYS PHARMA (HKEx), AYALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), TYME TECHNOLOGIES INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), CH BIOTECH SER (HKEx), IMMUNIC INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), ZHONGZHIPHARM (HKEx), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), BIOMX INC (NYSE American), IX Biopharma (SGX), CHECKPOINT THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), GENPREX INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), NC HEALTHCARE (HKEx), NEW RAY MEDIC (HKEx), CORVUS PHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), PAK FAH YEOW (HKEx), CHARMACY PHAR (HKEx), RECCE PHARMACEUTICALS LTD (ASX), TREVI THERAPEUTICS INC (NASDAQ), Hyphens Pharma (SGX), PALLA PHARMA LTD (ASX), Merck Tbk. (IDX), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), BAUDAX BIO INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), Phapros Tbk. (IDX), ARIDIS PHARMACEUTICAL INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), HISTOGEN INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), IP (SET), AERPIO PHARMACEUTICALS INC (NASDAQ), NEP INTERLONG (HKEx), CNS PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), WAI YUEN TONG (HKEx), TBG DIAGNOSTICS LTD (ASX), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), SANAI HEALTH GP (HKEx), ENTERA BIO LTD (NASDAQ), JCT (SET), TITAN PHARMACEUTICAL INC (NASDAQ), INVION LTD (ASX), MEDLAB CLINICAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), AGEX THERAPEUTICS INC (NYSE American), AILERON THERAPEUTICS INC (NASDAQ), PURAPHARM (HKEx), ACER THERAPEUTICS INC (NASDAQ), ANNOVIS BIO INC (NYSE American), NOXOPHARM LTD (ASX), SPRING BANK PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EXTRAWELL PHAR (HKEx), RACE ONCOLOGY LTD (ASX), PHARMAXIS (ASX), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), ACRUX (ASX), PROPHASE LABS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), CELLMID LIMITED (ASX), TALI DIGITAL LIMITED (ASX), CHINA SXT PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), PASHUN INT'L (HKEx), CRESO PHARMA LTD (ASX), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-5.76 %
10 Days -+0.145
+28.43 %
20 Days -+0.180
+37.89 %
Medium Term Return 3 Months --0.100
-13.25 %
6 Months --0.285
-30.32 %
1 Year --0.445
-40.45 %
Long Term Return 2 Years 0.050-1.855
-71.91 %
3 Years 0.160-2.075
-70.15 %
5 Years 0.535-2.180
-58.02 %
Annualised Return Annualised --
-15.94 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.345 - 1.260 Change From 1 Year Low +0.310 % Change From 1 Year Low (%) +89.86
Change From 1 Year High -0.605 % Change From 1 Year High (%) -48.02
2 Years Range 0.345 - 2.510 Change From 2 Years Low +0.310 % Change From 2 Years Low (%) +89.86
Change From 2 Years High -1.855 % Change From 2 Years High (%) -73.90
5 Years Range 0.345 - 3.070 Change From 5 Years Low +0.310 % Change From 5 Years Low (%) +89.86
Change From 5 Years High -2.415 % Change From 5 Years High (%) -78.66
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Boustead Holdings Berhad (Boustead), one of Malaysia's oldest diversified conglomerates, was founded in 1828 and over the last 178 years, it has grown to comprise more than 80 listed and non-listed subsidiaries and associate companies that span across a wide cross-section of the Malaysian economy today.

Listed on Bursa Malaysia in 1961, Boustead is a leading Government-linked company (GLC) in which Lembaga Tabung Angkatan Tentera (LTAT) is the majority shareholder, has total assets in excess of RM4 billion and more than 11,000 employees.


Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(2.70 MB)
Part 2(2.69 MB)
Annual Report 2017 Dec 2017 Part 1(2.74 MB)
Part 2(2.79 MB)
Part 3(0.79 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Part 2(2.71 MB)
Annual Report 2015 Dec 2015 Part 1(2.90 MB)
Part 2(2.74 MB)
Annual Report 2014 Dec 2014 Part 1(3.12 MB)
Part 2(2.59 MB)
Annual Report 2013 Dec 2013 Part 1(1.10 MB)
Part 2(2.68 MB)
Annual Report 2012 Dec 2012 Part 1(2.64 MB)
Part 2(1.77 MB)
Annual Report 2011 Dec 2011 Part 1(2.58 MB)
Annual Report 2010 Dec 2010 Part 1(2.85 MB)
Part 2(0.58 MB)
Annual Report 2009 Dec 2009 Part 1(0.16 MB)
Part 2(2.23 MB)
Part 3(1.82 MB)
Part 4(0.52 MB)
Annual Report 2008 Dec 2008 Part 1(2.28 MB)
Part 2(2.17 MB)
Annual Report 2007 Dec 2007 Part 1(1.84 MB)
Annual Report 2006 Dec 2006 Part 1(1.11 MB)
Annual Report 2005 Dec 2005 Part 1(1.17 MB)
Part 2(0.63 MB)
Part 3(0.96 MB)
Annual Report 2004 Dec 2004 Part 1(1.35 MB)
Part 2(0.47 MB)
Part 3(0.36 MB)
Part 4(1.65 MB)
Part 5(1.79 MB)
Part 6(1.20 MB)
Annual Report 2003 Dec 2003 Part 1(0.60 MB)
Part 2(0.37 MB)
Part 3(0.49 MB)
Annual Report 2002 Dec 2002 Part 1(0.66 MB)
Part 2(0.23 MB)
Part 3(0.49 MB)
Part 4(0.48 MB)
Annual Report 2001 Dec 2001 Part 1(0.74 MB)
Part 2(0.33 MB)
Part 3(0.34 MB)
Annual Report 2000 Dec 2000 Part 1(0.62 MB)
Part 2(0.33 MB)
Part 3(0.28 MB)
Annual Report 1999 Dec 1999 Part 1(1.00 MB)
Part 2(1.11 MB)
Part 3(1.05 MB)
Part 4(1.10 MB)
Part 5(0.41 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
05 Jun 2020 0.675 0.675 0.645 0.655 5,751,300 0.6577
04 Jun 2020 0.685 0.690 0.670 0.680 7,403,200 0.6802
03 Jun 2020 0.645 0.700 0.635 0.680 19,572,700 0.6727
02 Jun 2020 0.665 0.670 0.630 0.640 12,782,300 0.6423
01 Jun 2020 0.700 0.705 0.655 0.665 15,879,000 0.6719
29 May 2020 0.700 0.755 0.665 0.695 56,104,400 0.7146
28 May 2020 0.620 0.700 0.620 0.630 46,763,500 0.6448
27 May 2020 0.525 0.625 0.515 0.590 62,103,000 0.5771
22 May 2020 0.485 0.545 0.480 0.510 41,877,200 0.5149
21 May 2020 0.480 0.485 0.475 0.480 9,282,000 0.4800
20 May 2020 0.480 0.490 0.470 0.480 10,600,000 0.4812
19 May 2020 0.475 0.485 0.465 0.475 12,682,900 0.4783
18 May 2020 0.465 0.470 0.455 0.460 5,364,900 0.4603
15 May 2020 0.450 0.470 0.450 0.455 4,850,000 0.4577
14 May 2020 0.455 0.455 0.445 0.450 4,098,900 0.4493
13 May 2020 0.460 0.475 0.450 0.455 6,764,800 0.4615
12 May 2020 0.475 0.480 0.460 0.460 6,098,700 0.4669
08 May 2020 0.490 0.495 0.475 0.475 5,738,100 0.4827
06 May 2020 0.475 0.500 0.465 0.480 18,195,200 0.4849
05 May 2020 0.470 0.480 0.465 0.475 7,943,400 0.4729
04 May 2020 0.455 0.475 0.450 0.460 15,382,200 0.4657
30 Apr 2020 0.440 0.455 0.440 0.455 12,265,200 0.4465
Summary
Current 2 Weeks
(21 May 2020 to 05 Jun 2020)
0.480 0.755 0.475 0.655 277,518,600 -
Previous 2 Weeks
(05 May 2020 to 20 May 2020)
0.470 0.755 0.465 0.480 82,336,900 -
4 Weeks from
(06 Apr 2020 to 04 May 2020)
0.415 0.755 0.415 0.460 144,170,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.